Showing results (131-140 of 294) with videos related to
Sort By:
Pageof 30
Cell Cycle (Georgetown, Tex.)|May 22, 2014
Isg15 controls p53 stability and functionsYi-Fu Huang, Sheena Wee, Jayantha Gunaratne, et al.Proteins|June 19, 2016
Reactivation of mutant p53: Constraints on mechanism highlighted by principal component analysis of the DNA binding domainZahra Ouaray, Karim M ElSawy, David P Lane, et al.The Journal of Physical Chemistry. B|December 25, 2015
Recognition Dynamics of p53 and MDM2: Implications for Peptide DesignKarim M ElSawy, David P Lane, Chandra S Verma, et al.Nature Reviews. Cancer|November 26, 2009
Awakening guardian angels: drugging the p53 pathwayChristopher J Brown, Sonia Lain, Chandra S Verma, et al.Cell Cycle (Georgetown, Tex.)|January 14, 2015
A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2Karim M ElSawy, Adelene Sim, David P Lane, et al.Biosensors & Bioelectronics|April 25, 2013
A generic scaffold for conversion of peptide ligands into homogenous biosensorsSaurabh R Nirantar, Kun Song Yeo, Sharon Chee, et al.BMC Biology|May 24, 2019
Monitoring flux in signalling pathways through measurements of 4EBP1-mediated eIF4F complex assemblyYuri Frosi, Rachael Usher, Dawn Thean Gek Lian, et al.EJNMMI Research|April 18, 2020
Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2Anja C L Mortensen, Eric Morin, Christopher J Brown, et al.Cell Cycle (Georgetown, Tex.)|September 25, 2007
Substrate specificity of cyclins determined by electrostaticsHui Jun Lee, Gek Huey Chua, Arun Krishnan, et al.Cell Cycle (Georgetown, Tex.)|March 2, 2010
Differential binding of p53 and nutlin to MDM2 and MDMX: computational studiesThomas Leonard Joseph, Arumugam Madhumalar, Christopher J Brown, et al.Pageof 30